Urolithiasis: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett m (→Etiology/cause) |
imported>Robert Badgett |
||
| Line 19: | Line 19: | ||
==Prevention== | ==Prevention== | ||
[[Chlorthalidone]] reduces recurrence of calcium oxalate stones.<ref name="pmid3280829">{{cite journal| author=Ettinger B, Citron JT, Livermore B, Dolman LI| title=Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. | journal=J Urol | year= 1988 | volume= 139 | issue= 4 | pages= 679-84 | pmid=3280829 | [[Chlorthalidone]] reduces recurrence of calcium oxalate stones.<ref name="pmid3280829">{{cite journal| author=Ettinger B, Citron JT, Livermore B, Dolman LI| title=Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. | journal=J Urol | year= 1988 | volume= 139 | issue= 4 | pages= 679-84 | pmid=3280829 | ||
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=3280829 }} </ref> | | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=3280829 }} </ref><ref name="pmid19160242">{{cite journal| author=Escribano J, Balaguer A, Pagone F, Feliu A, Roqué I Figuls M| title=Pharmacological interventions for preventing complications in idiopathic hypercalciuria. | journal=Cochrane Database Syst Rev | year= 2009 | volume= | issue= 1 | pages= CD004754 | pmid=19160242 | ||
| url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&retmode=ref&cmd=prlinks&id=19160242 | doi=10.1002/14651858.CD004754.pub2 }} </ref> | |||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 12:28, 1 May 2010
In medicine, urolithiasis if the "formation of stones in any part of the urinary tract, usually in the kidney; urinary bladder; or the ureter."[1]
Classification
Etiology/cause
- Hypercalcuria - >140 mg/gm of urine creatinine or >4 mg/kg of body weight
- Hyperoxaluria - >40mg in 24 hour urine. May be primary or secondary to disorders such as inflammatory bowel disease
- Hypocitruria
- Uric acid
- Struvite
- Cysteine
Treatment
Prevention
Chlorthalidone reduces recurrence of calcium oxalate stones.[2][3]
References
- ↑ Anonymous (2024), Urolithiasis (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Ettinger B, Citron JT, Livermore B, Dolman LI (1988). "Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not.". J Urol 139 (4): 679-84. PMID 3280829.
- ↑ Escribano J, Balaguer A, Pagone F, Feliu A, Roqué I Figuls M (2009). "Pharmacological interventions for preventing complications in idiopathic hypercalciuria.". Cochrane Database Syst Rev (1): CD004754. DOI:10.1002/14651858.CD004754.pub2. PMID 19160242. Research Blogging.